Trademark: 86577541
Status Date
Tuesday, January 2, 2024
Registration Number
5239010
Registration Date
Tuesday, July 11, 2017
Filing Date
Thursday, March 26, 2015
Published for Opposition
Tuesday, April 25, 2017
5 [ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
1 [ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
44 Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
42 Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services
The wording "HEPTARES" has no meaning in a foreign language.
Jan 2, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 2, 2024
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 2, 2024
Case Assigned To Post Registration Paralegal
Jul 10, 2023
Teas Section 8 & 15 Received
Jul 11, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 6, 2020
Automatic Update Of Assignment Of Ownership
Oct 30, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 30, 2018
Teas Change Of Owner Address Received
Jul 11, 2017
Registered-Principal Register
Apr 25, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2017
Published For Opposition
Apr 5, 2017
Notification Of Notice Of Publication E-Mailed
Mar 17, 2017
Law Office Publication Review Completed
Mar 10, 2017
Approved For Pub - Principal Register
Feb 3, 2017
Teas/Email Correspondence Entered
Feb 3, 2017
Correspondence Received In Law Office
Feb 1, 2017
Teas Response To Office Action Received
Aug 5, 2016
Notification Of Non-Final Action E-Mailed
Aug 5, 2016
Non-Final Action E-Mailed
Aug 5, 2016
Non-Final Action Written
Jul 7, 2016
Notification Of Subsequent Final Emailed
Jul 7, 2016
Subsequent Final Emailed
Jul 7, 2016
Subsequent Final Refusal Written
Jun 15, 2016
Teas/Email Correspondence Entered
Jun 15, 2016
Correspondence Received In Law Office
Jun 15, 2016
Teas Request For Reconsideration Received
Mar 8, 2016
Notification Of Final Refusal Emailed
Mar 8, 2016
Final Refusal E-Mailed
Mar 8, 2016
Final Refusal Written
Feb 16, 2016
Teas/Email Correspondence Entered
Feb 16, 2016
Correspondence Received In Law Office
Feb 16, 2016
Teas Response To Office Action Received
Jan 20, 2016
Notification Of Notice Of Unresponsive Amendment - E-Mailed
Jan 20, 2016
Notice Of Unresponsive Amendment - E-Mailed
Jan 20, 2016
Report Unresponsive Amendment - Completed
Jan 20, 2016
Teas/Email Correspondence Entered
Jan 20, 2016
Correspondence Received In Law Office
Jan 15, 2016
Assigned To Lie
Jan 8, 2016
Teas Response To Office Action Received
Jul 12, 2015
Notification Of Non-Final Action E-Mailed
Jul 12, 2015
Non-Final Action E-Mailed
Jul 12, 2015
Non-Final Action Written
Jun 29, 2015
Assigned To Examiner
Jun 5, 2015
Preliminary/Voluntary Amendment - Entered
Jun 1, 2015
Assigned To Lie
May 27, 2015
Teas Voluntary Amendment Received
Apr 4, 2015
New Application Office Supplied Data Entered
Mar 30, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
